George L. Sing - Nov 16, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Stock symbol
REGN
Transactions as of
Nov 16, 2021
Transactions value $
-$7,025,080
Form type
4
Date filed
11/18/2021, 03:09 PM
Previous filing
Aug 30, 2021
Next filing
Nov 23, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$1.3M -2K -4.67% $650.00 40.9K Nov 16, 2021 Direct
transaction REGN Common Stock Sale -$1.32M -2K -4.9% $658.79 38.9K Nov 16, 2021 Direct
transaction REGN Common Stock Sale -$1.32M -2K -5.15% $660.00 36.9K Nov 16, 2021 Direct F1
transaction REGN Common Stock Sale -$2.6M -4K -10.85% $650.00 32.9K Nov 18, 2021 Direct
transaction REGN Common Stock Sale -$488K -750 -42.86% $650.00 1K Nov 16, 2021 by Trust for Son
holding REGN Common Stock 750 Nov 16, 2021 by Spouse
holding REGN Common Stock 400 Nov 16, 2021 by Spouse/Cust Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 2,000 shares of Company stock on November 16, 2021 at prices ranging from $660.00 to $660.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.